Sponsor Pipeline

Intra-Cellular Therapies, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
11
Active Trials
10
Recruiting
6
Phase 3
6
Disease Areas
7
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT06299410
PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284…
date change Completion moved earlier: 2026-10-30 -> 2026-08-19
2026-07-25 NCT06462586
Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania
Trial completed
2026-07-25 NCT06557902
Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With…
Trial completed
2026-07-25 NCT06557902
Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With…
Enrollment increased: 26 -> 33 participants
2026-07-25 NCT06557902
Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With…
date change Primary completion moved earlier: 2026-07-31 -> 2025-11-26
2026-07-25 NCT06557902
Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With…
date change Completion moved earlier: 2026-07-31 -> 2025-11-26
2026-07-25 NCT06462612
Study of Lumateperone in the Treatment of Patients With Bipolar Mania
Trial completed
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-05 NCT07747389 A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
6
Phase 2
4
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05850689 Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major… Major Depressive Disorder Recruiting
NCT06372964 Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric… Bipolar Depression Recruiting
NCT06690398 Multicenter Study of Lumateperone for the Treatment of Irritability Associated With… Irritability Associated With Autism Spectrum Disorder Recruiting
NCT06706674 Multicenter Study of Lumateperone for the Treatment of Irritability Associated With… Irritability Associated With Autism Spectrum Disorder Recruiting
NCT06229210 Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia… Schizophrenia Recruiting
NCT07747389 A Study of Lumateperone Versus Placebo in Participants With Major Depressive Disorder Depressive Disorder, Major Not Yet Recruiting
Phase 2
NCT06480383 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder Generalized Anxiety Disorder Recruiting
NCT06701903 Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder Generalized Anxiety Disorder Recruiting
NCT06540833 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis… Psychosis Associated With Alzheimer's Disease Recruiting
NCT06651567 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation… Agitation Associated With Alzheimer's Dementia Recruiting
Phase 1
NCT06299410 PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284… Healthy Volunteers Recruiting
Disease Areas
Get alerts when Intra-Cellular Therapies, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free